The medical device industry operates under strict oversight, and the recent release of the FDA’s final guidance on remanufacturing of medical devices represents a very important development for manufacturers, service providers and component suppliers. This article explores the key elements of this guidance, its implications for the industry, and how companies like Oxus are leading the way to ensure compliance.